alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
|   |
|---|
|   |  |
| 1 | I have reviewed this report on Form 10-K and all reports on Form 10-D required to be filed in respect of the period covered by this report on Form 10-K of Ally Auto Receivables Trust 2013-1 (the “Exchange Act periodic reports”); |

|   |
|---|
|   |  |
| 2 | Based on my knowledge, the Exchange Act periodic reports, taken as a whole, do not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |

|   |
|---|
|   |  |
| 3 | Based on my knowledge, all of the distribution, servicing and other information required to be provided under Form 10-D for the period covered by this report is included in the Exchange Act periodic reports; |

|   |
|---|
|   |  |
| 4 | Based on my knowledge and the servicer compliance statement required in this report under Item 1123 of Regulation AB, and except as disclosed in the Exchange Act periodic reports, the servicer has fulfilled its obligations under the servicing agreement in all material respects; and |

|   |
|---|
|   |  |
| 5 | All of the reports on assessment of compliance with servicing criteria for asset-backed securities and their related attestation reports on assessment of compliance with servicing criteria for asset-backed securities required to be included in this report in accordance with Item 1122 of Regulation AB and Exchange Act Rules 13a-18 and 15d-18 have been included as an exhibit to this report, except as otherwise disclosed in this report. Any material instances of noncompliance described in such reports have been disclosed in this report on Form 10-K. |

|                                                               |
|---------------------------------------------------------------|
|                                                               |  |
| /s/ Ryan C. Farris                                            |   |
|                                                          |
| Ryan C. Farris                                                |
| President, Ally Auto Assets LLC, as Depositor                 |
| (Senior Officer in charge of securitization of the depositor) |
EXHIBIT 31.2 CERTIFICATION OF ACTING
PRINCIPAL FINANCIAL OFFICER I, Mary E. Thomas, certify that: 1.
I
have reviewed this annual report on Form 10-KSB of Le@P Technology, Inc.  2.
Based
on my knowledge, this annual report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in light of
the circumstances under which such statements were made, not misleading with respect to
the period covered by this annual report;  3.
Based
on my knowledge, the consolidated financial statements, and other financial information
included in this annual report, fairly present in all material respects the financial
condition, results of operations and cash flows of the of the small business issuer as
of, and for, the periods presented in this annual report;  4.
The
registrants other certifying officer and I are responsible for establishing and
maintaining disclosure controls and            procedures (as defined in Exchange Act
Rules 13a-15r and 15d-18e) for the small business issuer and have;  d)
designed
such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information
relating to the small business issuer, including its consolidated subsidiaries, is made
known to us by others within those entities, particularly during the period in which this
annual report is being prepared;  e)
evaluated
the  effectiveness  of the small  business  issuers  disclosure  controls and
 procedures as the end of                      period covered by of this annual report
based on such evaluation; and  f)
disclosed
in this report any change in the small business issuers internal control over
financial reporting that occurred during the small business issuers most recent
fiscal quarter that has materially affected, or is reasonably likely to materially
affect, the small business issuers internal control over financial reporting; and  5.
The
small business issuers other certifying officer and I have disclosed, based on our
most recent evaluation, to the small business issuers auditors and the audit
committee of small business issuers board of directors (or persons performing the
equivalent functions):  c)
all
significant deficiencies in the design or operation of internal controls which could
adversely affect the small business issuers ability to record, process, summarize
and report financial data and have identified for the small business issuers
auditors any material weaknesses in internal controls; and  d)
any
fraud, whether or not material, that involves management or other employees who have a
significant role in the small business issuers internal controls.  Date:  March 23, 2005  /s/ Mary E. Thomas
Mary E. ThomasActing
Principal Financial Officer
Exhibit 10.61

 

AMENDMENT NO. 1 TO SALE BONUS LETTER AGREEMENT

 

This Amendment No. 1 to the Sale Bonus Letter Agreement (this “Amendment”) is entered into as of December 2, 2011, by and between (i) Mark C. Arnold (“you”) and (ii) GSE Holding, Inc. (the “Company”).  You and the Company are collectively referred to herein as the “Parties” and individually as a “Party.”  Unless otherwise specified herein, capitalized terms used in this Amendment have the meanings set forth in the Sale Bonus Letter Agreement (as defined below).

 

WHEREAS, the Parties are each a party to that certain Sale Bonus Letter Agreement, dated as of March 4, 2010 (as amended, the “Sale Bonus Letter Agreement”).

 

WHEREAS, Section 4(a) of the Sale Bonus Letter Agreement provides that amendments may be made to the Sale Bonus Letter Agreement by execution of a writing signed by you and the Company.

 

WHEREAS, you and the Company wish to amend certain provisions of the Sale Bonus Letter Agreement as set forth herein.

 

NOW, THEREFORE, you and the Company hereby agree as follows:

 

1.                                       Section 4(f). A new Section 4(f) is hereby added to the Sale Bonus Letter Agreement to read as follows:

 

“(f)                              This Agreement will automatically terminate upon the consummation of an “Initial Public Offering” (as defined in that certain IPO Bonus and Dividend Bonus Letter Agreement, dated as of September 16, 2010, by and between you and the Company, as amended by that certain Amendment No. 1, dated as of the date hereof).”

 

2.                                       Miscellaneous.  The provisions of the Sale Bonus Letter Agreement set forth in Section 4 thereof shall apply mutatis mutandis to this Amendment. The Sale Bonus Agreement, as amended hereby, is and remains in full force and effect.

 

*        *        *        *        *

 











 

IN WITNESS WHEREOF, the Parties set forth below have executed this Amendment as of the date first above written.

 

	
 
    	
GSE HOLDING, INC.
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ William F. Lacey
    
	
 
    	
Name:
    	
William F. Lacey
    
	
 
    	
Its:
    	
Chief Financial Officer
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
/s/ Mark C. Arnold
    
	
 
    	
Name:
    	
Mark C. Arnold
    


 

Signature Page to Amendment No. 1 to the Sale Bonus Letter Agreement
[Federal Register Volume 82, Number 165 (Monday, August 28, 2017)]
[Notices]
[Page 40745]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-18309]


=======================================================================
-----------------------------------------------------------------------

BROADCASTING BOARD OF GOVERNORS


Sunshine Act Meeting

DATE AND TIME:  Wednesday, August 30, 2017, 1:30 p.m. EDT.

PLACE:  Broadcasting Board of Governors, Cohen Building, Room 3321, 330 
Independence Ave. SW., Washington, DC 20237.

SUBJECT:  Notice of Closed Meeting of the Broadcasting Board of 
Governors.
SUMMARY: The members of the Broadcasting Board of Governors (BBG) will 
meet in a special session to discuss and approve a budget submission 
for Fiscal Year 2019. According to Office of Management and Budget 
(OMB) Circular A-11, Section 22.1, all agency budgetary materials and 
data are considered confidential prior to the President submitting a 
budget to Congress. In accordance with section 22.5 of Circular A-11, 
the BBG has determined that its meeting should be closed to public 
observation pursuant to 5 U.S.C. 552b(c)(9)(B). In accordance with the 
Government in the Sunshine Act and BBG policies, the meeting will be 
recorded and a transcript of the proceedings, subject to the redaction 
of information protected by 5 U.S.C. 552b(c)(9)(B), will be made 
available to the public. The publicly-releasable transcript will be 
available for download at www.bbg.gov within 21 days of the date of the 
meeting.
    Information regarding member votes to close the meeting and 
expected attendees can also be found on the Agency's public Web site.

CONTACT PERSON FOR MORE INFORMATION:  Persons interested in obtaining 
more information should contact Oanh Tran at (202) 203-4545.

Oanh Tran,
Managing Director.
[FR Doc. 2017-18309 Filed 8-24-17; 4:15 pm]
 BILLING CODE 8610-01-P
[Federal Register Volume 82, Number 166 (Tuesday, August 29, 2017)]
[Notices]
[Page 41011]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-18240]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

[Docket No. OR17-21-000]

Federal Energy Regulatory Commission


Grieve Pipeline, LLC; Notice of Petition for Declaratory Order

    Take notice that on August 11, 2017, pursuant to Rule 207(a)(2) of 
the Federal Energy Regulatory Commission's (Commission) Rules of 
Practice and Procedure, 18 CFR 385.207(a)(2) (2016), Grieve Pipeline, 
LLC, a subsidiary of Elk Petroleum, Inc., filed a petition for a 
declaratory order seeking approval of open season procedures, rate 
structure, key contract and tariff terms, as more fully explained in 
the petition.
    Any person desiring to intervene or to protest this filing must 
file in accordance with Rules 211 and 214 of the Commission's Rules of 
Practice and Procedure (18 CFR 385.211, 385.214). Protests will be 
considered by the Commission in determining the appropriate action to 
be taken, but will not serve to make protestants parties to the 
proceeding. Any person wishing to become a party must file a notice of 
intervention or motion to intervene, as appropriate. Such notices, 
motions, or protests must be filed on or before the comment date. 
Anyone filing a motion to intervene or protest must serve a copy of 
that document on the Petitioner.
    The Commission encourages electronic submission of protests and 
interventions in lieu of paper using the eFiling link at http://www.ferc.gov. Persons unable to file electronically should submit an 
original and 5 copies of the protest or intervention to the Federal 
Energy Regulatory Commission, 888 First Street NE., Washington, DC 
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the 
eLibrary link and is available for review in the Commission's Public 
Reference Room in Washington, DC. There is an eSubscription link on the 
Web site that enables subscribers to receive email notification when a 
document is added to a subscribed docket(s). For assistance with any 
FERC Online service, please email <a href="/cdn-cgi/l/email-protection#c1878493828eafada8afa492b4b1b1aeb3b581a7a4b3a2efa6aeb7"><span class="__cf_email__" data-cfemail="c5838097868aaba9acaba096b0b5b5aab7b185a3a0b7a6eba2aab3">[email protected]</span></a>, or call 
(866) 208-3676 (toll free). For TTY, call (202) 502-8659.
    Comment Date: 5:00 p.m. Eastern time on September 11, 2017.

    Dated: August 22, 2017.
 Kimberly D. Bose,
Secretary.
[FR Doc. 2017-18240 Filed 8-28-17; 8:45 am]
BILLING CODE 6717-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<PAGE>
                                                                    EXHIBIT 99.1

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly Report on Form 10-Q of Health Fitness
Corporation (the "Company") for the period ended September 30, 2002, as filed
with the Securities and Exchange Commission on November 12, 2002 (the "Periodic
Report"), I, Jerry V. Noyce, Chief Executive Officer of the Company, hereby
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:

     1.  The Periodic Report fully complies with the requirements of section
         13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or
         78o(d)); and

     2.  The information contained in the Periodic Report fairly presents, in
         all material respects, the financial condition and results of
         operations of the Company.



/s/ Jerry V. Noyce


Jerry V. Noyce
Chief Executive Officer
Health Fitness Corporation
November 12, 2002
II 

114TH CONGRESS 

1ST SESSION S. 971 

To amend title XVIII of the Social Security Act to provide for an increase 

in the limit on the length of an agreement under the Medicare independence at home medical practice demonstration program. 

IN THE SENATE OF THE UNITED STATES 

APRIL 16, 2015 

Mr. WYDEN (for himself, Mr. MARKEY, Mr. BENNET, Mr. ISAKSON, and Mr. 

BURR) introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To amend title XVIII of the Social Security Act to provide 

for an increase in the limit on the length of an agreement 

under the Medicare independence at home medical practice demonstration program. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Medicare Independence 

5 at Home Medical Practice Demonstration Improvement 

6 Act of 2015’’. 

mstockstill on DSK4VPTVN1PROD with BILLS

2 

•S 971 IS

1 SEC. 2. INCREASE IN THE LIMIT ON THE LENGTH OF AN 

2 AGREEMENT UNDER THE MEDICARE INDE3 PENDENCE AT HOME MEDICAL PRACTICE 

4 DEMONSTRATION PROGRAM. 

5 Section 1866E(e)(1) (42 U.S.C. 1395cc–5(e)(1)) is 

6 amended by striking ‘‘3-year’’ and inserting ‘‘5-year’’. 

Æ 

mstockstill on DSK4VPTVN1PROD with BILLS
Exhibit 32.2
 CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
  (1)
    
    The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934 (15 U.S.C 78m or 78o(d));
and(2)
    
    The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations
of the Company.
 Date:   June 9, 2011
    /s/ Joseph G. MahlerJoseph G. MahlerSenior Vice President, Chief Financial Officer,
Treasurer and Corporate Secretary
(Principal Financial Officer and Principal Accounting
Officer)
<PAGE>
                                                                     EXHIBIT 3.1



                            CERTIFICATE OF AMENDMENT

                                       TO

                          CERTIFICATE OF INCORPORATION

                                       OF

                         TEXAS BIOTECHNOLOGY CORPORATION


         Texas Biotechnology Corporation (the "Corporation"), a corporation
organized and existing under the General Corporation Law of the State of
Delaware (the "DGCL"), hereby certifies as follows:

         FIRST: That at a meeting of the Board of Directors of the Corporation
on March 21, 2003, resolutions were duly adopted setting forth a proposed
amendment to the Certificate of Incorporation of the Corporation, declaring said
amendment to be advisable and calling a meeting of the stockholders of the
Corporation for consideration thereof. The resolution setting forth the proposed
amendment is as follows:

                  RESOLVED, that Article FIRST of the Certificate of
         Incorporation of the Corporation, as amended, shall be amended to read
         as follows:

                           FIRST: The name of the corporation is Encysive
                  Pharmaceuticals Inc. (hereinafter referred to as the
                  "Corporation").

         SECOND: That thereafter, pursuant to resolution of its Board of
Directors, a meeting of the stockholders of the Corporation was duly called and
held, upon notice in accordance with Section 222 of the DGCL, at which meeting
the holders of a majority of the shares of issued and outstanding common stock,
par value $.005 per share, of the Corporation voted in favor of the foregoing
amendment.

         THIRD: That the foregoing amendment to the Certificate of Incorporation
was duly adopted by the stockholders of the Corporation on May 16, 2003 pursuant
to the applicable provisions of Section 242 of the DGCL.

         IN WITNESS WHEREOF, the undersigned, being the duly authorized
Secretary of the Corporation, for the purpose of amending the Certificate of
Incorporation of the Corporation pursuant to Section 242 of the DGCL, does make
and file this Certificate of Amendment this 16th day of May, 2003.


                                     TEXAS BIOTECHNOLOGY CORPORATION


                                     By:   /s/  STEPHEN L. MUELLER
                                        ---------------------------------------
                                           Stephen L. Mueller, Secretary
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF ARROW INTERNATIONAL, INC. FOR THE QUARTER ENDED NOVEMBER
30, 1996 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          AUG-31-1997
<PERIOD-END>                               NOV-30-1996
<CASH>                                           7,763
<SECURITIES>                                         0
<RECEIVABLES>                                   51,981
<ALLOWANCES>                                       805
<INVENTORY>                                     45,350
<CURRENT-ASSETS>                                13,218
<PP&E>                                         163,118
<DEPRECIATION>                                  52,423
<TOTAL-ASSETS>                                 305,548
<CURRENT-LIABILITIES>                           57,429
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        45,580
<OTHER-SE>                                     180,228
<TOTAL-LIABILITY-AND-EQUITY>                   305,548
<SALES>                                         59,190
<TOTAL-REVENUES>                                59,190
<CGS>                                           27,405
<TOTAL-COSTS>                                   45,173
<OTHER-EXPENSES>                                    91
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 461
<INCOME-PRETAX>                                 13,465
<INCOME-TAX>                                     5,184
<INCOME-CONTINUING>                              8,281
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     8,281
<EPS-PRIMARY>                                      .36
<EPS-DILUTED>                                      .36
        

</TABLE>
# Fourth Court of Appeals

**San Antonio, Texas**

MEMORANDUM OPINION

No. 04

- 20

- 00434

- CV

IN RE PRONTO GENERAL AGENCY, LTD.

Original Mandamus Proceeding 1

PER CURIAM

Sitting: Patricia O. Alvarez, Justice

Irene Rios , Justice Liza A. Rodriguez , Justice

Delivered and Filed: January 20, 2021

PETITION FOR WRIT OF MANDAMUS DENIED

On September 4 , 2020, Relator filed a petition for writ of mandamus. On September 8,

2020, this court requested the real party in interest file a response. After considering the petition,

the record, and the response filed by the real party in interest, this court concludes Relator is not

entitled to the relief sought. Accordingly, the petition for writ of mandamus is denied. See T EX

. R.

A PP

. P. 52.8(a).

PER CURIAM

1 This proceeding arises out of C ause No. 2019CV01852 , styled Red McCombs Ford (Plaintiff) v. Olivia Moreno Rodriguez and Eric Rafael Castorena (Defendants and Third

- Party Plaintiffs) v. Pronto General Agency, Ltd. and CEM Insurance Company (Defendants and Third

- Party Defendants) , pending in the County Court at Law No. 10

, Bexar County, Texas, the Honorable David J. Rodriguez presiding.
##### 



Exhibit 31.2
 Certification of Chief Financial Officer pursuant to Rule 13a-14(a) / Rule 15d-14(a),
promulgated under the Securities Exchange Act of 1934, as amended.
  1.
    
    I have reviewed this quarterly report on Form 10-Q of Encysive Pharmaceuticals Inc.;2.
    
    Based on my knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this report;3.
    
    Based on my knowledge, the financial statements, and other financial information included in
this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this
report;4.
    
    The registrants other certifying officer(s) and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and have:
     5.
    
    The registrants other certifying officer(s) and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and the




---



##### 



audit committee of the registrants board of directors (or persons performing the equivalent
functions):
    /s/ Gordon H. BusenbarkGordon H. BusenbarkChief Financial Officer
 2